Cancers are all too common in our veterinary patients. For years, treatment strategies have been fairly stagnant, but advances in diagnostic and treatment options are opening new horizons for therapy. In this session we will discuss new strategies that can be applied to cancers in both referral and private practice settings.

12:00 – 1:00 pm
Treating Canine Melanoma
Melanoma is the most common oral malignancy in dogs. In this session, we will discuss the role of traditional therapies (surgical removal, radiation therapy, chemotherapy) and newer therapeutic approaches including immunotherapy and personalized medicine strategies.

1:00 – 2:00 pm
Mast Cell Tumor Updates
Mast cell tumors are the most common dermal malignancy in dogs and have a range of biologic behaviors. How can we best prognosticate these tumors to optimize outcomes for our patients? What are the newest strategies available to tackle this difficult cancer?

2:00 – 3:00 pm
New Kids on the Block – Small Molecular Inhibitors in Veterinary Cancer Medicine
Advances in the understanding of cancer biology have introduced new treatment options. In this session, we will discuss molecular profiling of tumors and new therapy approaches based on available small molecular inhibitors to target specific mutations.

3:00 – 4:00 pm
What’s New in Lymphoma?
Lymphoma is the most commonly treated disseminated cancer in veterinary medicine. Some older therapies are still standard of care, but new drugs and approaches are being investigated to improve outcomes for our veterinary patients.